GlassScriptPhysician profile
Ryan D Dempewolf
NPI 1912116492
$2,115.58
in general payments reported to CMS, 2019-2025
10 companies · $53.52 in 2025
The $53.52 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $12.24 · 2021: $41.61 · 2022: $178 · 2023: $1,694 · 2024: $30.66 · 2025: $53.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,096 · Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.10 |
| Food and Beverage | $682.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,462.53 | 2023 | Sinuva |
| Inspire Medical Systems, INC. | $348.11 | 2022-2023 | Inspire |
| Stryker Corporation | $75.98 | 2019-2025 | Claw II, Smart Toe, Augment Injectable |
| Aerin Medical INC. | $69.05 | 2019-2025 | |
| Intersect Ent, INC. | $53.78 | 2020-2022 | |
| Karl Storz Endoscopy-America | $33.06 | 2022 | |
| Acclarent, INC | $29.09 | 2021 | |
| Medtronic USA, INC. | $14.95 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $14.77 | 2025 | Neffy |
| Optinose US, INC. | $14.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dempewolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.